The Statin Controversy

What is The Statin Controversy?


The statin controversy is a serious dispute between the phamaceutical companies, the health service and numerous medical experts around the world about the value of statins as a protection against heart disease. You can read all about it in a booklet called “The Statin Controversy – And How To Resolve It" by Geoffrey Galley which is available through as a booklet and is also available as an ebook.

A key feature of the publication is that it offers a way of resolving the controversy which has continued for over three decades with no attempt being made by big pharma or the health services to address the valid concerns of those who believe that statins are effectively useless and likely to damage the health of those who use them.

This website is intended to provide a forum for those interested in understanding and resolving the statin controversy. Following the launch of the booklet, it will be used to follow the progress of the campaign to resolve the controversy while at the same time updating information provided in the booklet and advancing novel and effective methods of treating heart disease in both young and old alike.

I  read “The  Statin  Controversy and how to resolve it”  in  less than three hours.  It's  a  very  well  ordered  and  arranged cautionary  argument,  wrapped  up  in  under  100  pages.  It's also pretty scary.  OK,  last  year  I nudged my  blood  sugar  up  0.1  of  a  percent  over  the  diabetes  threshold,  and  voila,  I  am  now officially  diabetic.  I  keep  getting  statins  pushed  at  me  by  the  doctors.  While  I  have  staved  off their  advances  so  far,  they  like  to  remind  me  that  unless  I  get  my  cholesterol  down,  I  will have  to  take  them.  Next  time,  I'm  going  to  print  this  off  and  have  them  read  it!  It’s authoritative, unbiased, well researched and quite persuasive.


In  this  manuscript,  a  simple  situation  of  health  benefits  over  potential  risks  with  a  single  pill acts  to  uncover  different  machinations  of  the  health  sector.  Big  Pharma,  ever  present, pulling  the  strings  of  the  masses  and  other  entities  with  its  sheer  bulldog  girth,  is  exposed  as much  as  the  organisations  and  mind sets  that  are  brainwashed.  What  the  author  does  here  is to  codify  an  existing  argument  -  one  that  has  featured  prominently  on  the  news  -  and  place it  in  a  handy,  comprehensive,  but  digestible  form.  Analysing  purported  benefits  and  risks  of statin  therapy,  he  uncovers  some  interesting  nuggets  in  the  facts  and  figures.  What's  more, all  of  the  information  is  readily  available,  so  checking  in  with  the  author's  resources  is  possible.  It  all  boils  down  to  -  are  statins  helping  people  live  longer,  or  are  they  causing  more  harm  than  good  with  their  interference in biochemistry  and  possibly  dangerous  side  effects?  When  studies  point  to  patient’s  lives  increased  by  'days'  after  five  years  of  taking  the drug,  well,  we  should  take  notice.  But,  again,  the  pharmaceutical  industries  have  the  ear  of the  world  -  'take  our  drug,  you  won't  have  a  heart  attack',  even  though  heart  disease  is going  to  be  a  potential  killer  the  longer  and  longer  we  live  anyway.  


You have to die of something, right?  And are statins helping people die or have a heart attack later?   Well, the evidence doesn't appear so.   There's a lot of info here  beyond  the  pith  of  the  debate,  including  handy  sections  of  heart disease  in  general,  and  cholesterol  -  and  they  contain  examples  of  how  we  have  been misled,  whether  intentionally  or  out  of  ignorance.  It's  written  well,  is  very  tidy  and  has  the academic/research  quality  to  back  it  up.  It  all  leads  to  one  conclusion  -  get  Parliament to  step  in  and  order an independent review that establishes what has happened to statin users who have been taking the drug for more than ten years in the real world and compare their health and longevity with similar individuals with the same characteristics as the statin takers who haven’t taken the drugs.  Find out whether they kill or cure before giving them to half the population over 50. The author is right this would quickly bring an end to the statin controversy. This is well done indeed.

Critique of the booklet by the publisher's reader

@2018 by The Statin Controversy